Skip to content
Sunday, November 8, 2026
Explore Urban VIP Market for a curated selection of premium…

The Zimbabwean Government Declines ‘Lopsided’ American Healthcare Assistance Agreement Because of Data Fears

Health aid illustration
The offered US funding was aimed at programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has rejected a substantial American healthcare agreement worth 367 million US dollars (£272m) spanning five years over Washington's demand for confidential biological samples.

This rejection came to light after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".

An official representative has since stated that the US was seeking biological samples for scientific study and profit but was not willing to guarantee the resulting advantages from future vaccines.

"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has appealed for more negotiations to reach a deal agreeable to all parties so the country's critical HIV programme can proceed.

Wider Context

Zimbabwe's decision follows a similar situation in Kenya, where a court halted a related health funding agreement following legal challenges were raised about the security of Kenyans' medical information.

After returning to office last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had overseen aid for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking direct bilateral agreements to boost openness and responsibility.

Based on statements, Sixteen African countries have so far signed these new agreements, constituting over $18.3bn in new funding.

Details of the Declined Deal

This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this cooperation might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment through American-funded programmes," Tremont commented.

However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".

"Our nation was requested to provide its biological resources and data for a long time, with no equivalent guarantee of benefiting from any medical innovations – like new medicines or tests – that could result from that shared data," Mangwana explained.

"In essence, our nation would supply the basic resources for scientific discovery without any certainty that the end products would be accessible to our people if a future health crisis emerge."

Sovereignty and International Frameworks

He also said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining frameworks already set up through the global health agency.

Mangwana cited its Pandemic Benefit-Sharing framework created to manage potential pandemics.

"This mechanism is intended to ensure that when a nation provides its information, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," he added.

"We are open to continued dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the independence and interests of each country."

Medical Community Response

Medical experts said it recognised the government's concerns, but recommended that talks must proceed since a large portion of the nation's Aids initiatives relied on external financing.

"In cases where technical issues exist, including those involving data governance or implementation frameworks, these can frequently be addressed via technical clarification and negotiated safeguards," the group commented.

The halted deal underscores the complex debate between accepting much-needed international aid and protecting national sovereignty in an increasingly data-driven world.

TC
Written by

Tara Crane

Alex Rivera is a fashion enthusiast and lifestyle blogger with a keen eye for urban trends and exclusive products.

Urban VIP Market

Type to search articles.